Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Lixisenatide Acetate
Cat No.
CEPP-008
Description
Lixisenatide Acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes. As a synthetic GLP-1 analog, lixisenatide mimics the action of natural GLP-1 to help regulate blood glucose levels.
Applications
Diabetes Management
Regulating Blood Glucose: Lixisenatide Acetate enhances insulin secretion and inhibits glucagon release, making it particularly effective in managing postprandial (after meal) hyperglycemia. It helps patients with type 2 diabetes better control their blood glucose levels after meals.
Delaying Gastric Emptying: By slowing gastric emptying, lixisenatide reduces the rate at which glucose is absorbed, leading to more stable blood glucose levels and reducing rapid spikes after meals.
Low Risk of Hypoglycemia: Because its action is dependent on blood glucose levels, lixisenatide has a relatively low risk of causing hypoglycemia, especially when used in combination with other antidiabetic medications.
Weight Management
Appetite Suppression: Lixisenatide acts on the appetite centers in the brain to suppress appetite, helping patients reduce food intake. This is particularly beneficial for overweight or obese patients with type 2 diabetes, aiding in weight management.
Cardiovascular Health
Cardiovascular Protection: Some studies suggest that GLP-1 receptor agonists may have cardiovascular benefits. Although more research is needed to confirm this, lixisenatide may help reduce cardiovascular risk in patients with type 2 diabetes.
Regulating Blood Glucose: Lixisenatide Acetate enhances insulin secretion and inhibits glucagon release, making it particularly effective in managing postprandial (after meal) hyperglycemia. It helps patients with type 2 diabetes better control their blood glucose levels after meals.
Delaying Gastric Emptying: By slowing gastric emptying, lixisenatide reduces the rate at which glucose is absorbed, leading to more stable blood glucose levels and reducing rapid spikes after meals.
Low Risk of Hypoglycemia: Because its action is dependent on blood glucose levels, lixisenatide has a relatively low risk of causing hypoglycemia, especially when used in combination with other antidiabetic medications.
Weight Management
Appetite Suppression: Lixisenatide acts on the appetite centers in the brain to suppress appetite, helping patients reduce food intake. This is particularly beneficial for overweight or obese patients with type 2 diabetes, aiding in weight management.
Cardiovascular Health
Cardiovascular Protection: Some studies suggest that GLP-1 receptor agonists may have cardiovascular benefits. Although more research is needed to confirm this, lixisenatide may help reduce cardiovascular risk in patients with type 2 diabetes.
Package
1G/Bottle, 10G/Bottle, 50G/Bottle or at customers reqirement.
CAS No.
827033-10-3
Molecular Weight
4858.49
Purity
98%
Storage
-20°C
Molecular Formula
C215H347N61O65S
Amino Acid Sequence
H–His–Gly–Glu–Gly–Thr–Phe–Thr–Ser–Asp–Leu–Ser–Lys–Gln–Met–Glu–Glu–Glu–Ala–Val–Arg–Leu–Phe–Ile–Glu–Trp–Leu–Lys–Asn–Gly–Gly–Pro–Ser–Ser–Gly–Ala–Pro–Pro–Ser–Lys–Lys–Lys–Lys–Lys–Lys–Nh2
Download
Download Datasheet